efpegerglucagon (HM15136) / Hanmi  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
efpegerglucagon (HM15136) / Hanmi
NCT04032782: A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136 in Healthy Subjects

Completed
1
40
RoW
HM15136, Placebo of HM15136
Hanmi Pharmaceutical Company Limited
Pharmacology
08/19
08/19
NCT04167553: Study for Multiple Doses of HM15136 in Obese or Overweight Subjects With Comorbidities

Completed
1
53
US
HM15136, Placebo
Hanmi Pharmaceutical Company Limited
Obese With Comorbidities, Overweight With Comorbidities, Type2 Diabetes
12/20
12/20

Download Options